ALDX
Aldeyra Therapeutics Inc
Price:  
3.91 
USD
Volume:  
247,674.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ALDX WACC - Weighted Average Cost of Capital

The WACC of Aldeyra Therapeutics Inc (ALDX) is 9.7%.

The Cost of Equity of Aldeyra Therapeutics Inc (ALDX) is 10.10%.
The Cost of Debt of Aldeyra Therapeutics Inc (ALDX) is 5.00%.

Range Selected
Cost of equity 7.90% - 12.30% 10.10%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.6% - 11.8% 9.7%
WACC

ALDX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.87 1.33
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.90% 12.30%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.07 0.07
Cost of debt 5.00% 5.00%
After-tax WACC 7.6% 11.8%
Selected WACC 9.7%